Related Experiment Video

Updated: Mar 29, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

36.1K

Therapeutic Value of an Integrin Antagonist in Prostate Cancer

Clément-Lacroix Philippe1

  • 1Galapagos SASU. 102, Avenue Gaston Roussel, 93230 Romainville, France. Philippe.Clement-Lacroix@glpg.com.

Current Drug Targets
|December 10, 2015
PubMed

Insights

Integrin receptors are crucial in prostate cancer progression, influencing cell behavior and metastasis. Targeting integrins offers promising new therapeutic strategies for advanced prostate tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Integrin receptors play a significant role in cancer biology.
  • These receptors regulate critical cellular processes including survival, proliferation, differentiation, and migration.
  • Prostate cancer development and progression are areas of intense research interest.

Purpose of the Study:

  • To review the current understanding of integrin signaling mechanisms in metastatic prostate cancer.
  • To explore the crosstalk between primary and metastatic sites in tumor growth.
  • To examine tumor cell interactions with the tissue microenvironment and epithelial-mesenchymal transition (EMT).
  • To present integrin-based chemotherapeutic agents in clinical development.

Main Methods:

  • Literature review of recent research on integrin signaling in prostate cancer.
  • Analysis of studies investigating tumor microenvironment interactions.
  • Examination of clinical trial data for integrin-targeting therapies.

Main Results:

  • Integrins are key regulators of prostate tumor cell survival, proliferation, migration, and differentiation.
  • Bidirectional communication between primary and metastatic sites influences tumor growth.
  • Tumor cell interactions with the microenvironment, including EMT, are mediated by integrins.
  • Several integrin-based agents are under clinical investigation for cancer therapy.

Conclusions:

  • Integrin signaling is fundamental to metastatic prostate cancer development.
  • Targeting integrins presents a viable strategy for novel prostate cancer therapeutics.
  • Further research into integrin pathways and targeted therapies is warranted.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.0K
Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis07:48

Preparing a 68Ga-labeled Arginine Glycine Aspartate RGD-peptide for Angiogenesis

Published on: January 7, 2019

7.4K

Related Concept Videos

Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.5K
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
6.1K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
602
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K